Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) Gross Margin (2020 - 2025)

Historic Gross Margin for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to 63.06%.

  • Rapid Micro Biosystems' Gross Margin rose 74600.0% to 63.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 61.53%, marking a year-over-year increase of 129100.0%. This contributed to the annual value of 52.71% for FY2024, which is 118700.0% up from last year.
  • Rapid Micro Biosystems' Gross Margin amounted to 63.06% in Q3 2025, which was up 74600.0% from 57.12% recorded in Q2 2025.
  • Rapid Micro Biosystems' Gross Margin's 5-year high stood at 63.71% during Q4 2024, with a 5-year trough of 5.72% in Q4 2022.
  • For the 5-year period, Rapid Micro Biosystems' Gross Margin averaged around 41.72%, with its median value being 45.19% (2024).
  • Its Gross Margin has fluctuated over the past 5 years, first plummeted by -393300bps in 2022, then soared by 444000bps in 2023.
  • Over the past 5 years, Rapid Micro Biosystems' Gross Margin (Quarter) stood at 35.58% in 2021, then crashed by -84bps to 5.72% in 2022, then soared by 777bps to 50.12% in 2023, then increased by 27bps to 63.71% in 2024, then fell by -1bps to 63.06% in 2025.
  • Its Gross Margin was 63.06% in Q3 2025, compared to 57.12% in Q2 2025 and 61.82% in Q1 2025.